Maximum Dosage of Nifedipine ER for Hypertension
The maximum recommended dose of nifedipine extended-release (ER) for hypertension is 90 mg once daily, though doses up to 120 mg daily have been studied and used in clinical practice. 1
FDA-Approved Dosing
According to the FDA drug label, nifedipine ER demonstrates dose-proportional pharmacokinetics when administered as multiples of 30 mg tablets over a dose range of 30 mg to 90 mg 1. However, there is an important caveat: three 30 mg tablets should NOT be considered interchangeable with a single 90 mg tablet because the three separate 30 mg tablets result in substantially higher peak plasma concentrations (Cmax values 29% greater than predicted) 1.
Clinical Practice Evidence
While the FDA label emphasizes the 90 mg dose, clinical research demonstrates that:
Doses up to 120 mg daily have been successfully used in clinical trials for mild-to-moderate hypertension, with more than 50% of patients controlled on 30-60 mg/day 2, 3
Doses up to 180 mg daily were studied in the large MATH trial involving 1,155 patients, though most patients responded to lower doses 3
80 mg daily has been specifically studied in Japanese populations with favorable safety profiles and no reported side effects 4
Practical Dosing Algorithm
- Start at 30 mg once daily under fasting conditions
- Titrate every 4 weeks based on blood pressure response
- Target dose range: 30-90 mg once daily for most patients
- Maximum practical dose: 90 mg once daily (using either one 90 mg tablet or two 30 mg tablets, NOT three 30 mg tablets)
- Consider up to 120 mg daily only in refractory cases with careful monitoring
Important Caveats
Food interactions matter: Taking nifedipine ER immediately after a high-fat meal increases peak plasma concentration by 60% and prolongs time to peak concentration, though total drug exposure (AUC) remains unchanged 1. For consistent dosing, administer under similar dietary conditions daily.
Special populations require dose adjustment:
- Hepatic impairment: Nifedipine has longer elimination half-life and higher bioavailability in liver cirrhosis patients 1
- Elderly patients (>60 years): Mean Cmax is 36% higher and average plasma concentration is 70% greater than younger patients 1
- Renal disease: Exercise caution as absorption may be modified, though hemodialysis patients show no significant pharmacokinetic alterations 1
Peripheral edema is dose-dependent: Incidence increases from 18% at 30 mg daily to 29% at 90 mg daily 1. Bedtime dosing reduces edema incidence by 91% compared to morning dosing 5.